Today's top medical abstracts
Internal Med
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Internal Med
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Internal Med
        Academic Med/Education
        Adolescent Medicine
        Allergy/Immunology
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Cardiology
        Clinical Pharmacology
        Complementary Medicine
        Critical Care/
    Hospitalist
        Dermatology
        Economics of Medicine
        Endocrinology
        Epidemiology
        Gastroenterology
        Geriatrics
        Hematology/Oncology
        Infectious Disease
        Nephrology/Urology
        Neurology
        Orthopedic/Physical Med
        Popular Press
        Preventive Medicine
        Primary Care
        Psychiatry
        Pulmonology
        Radiology/Diagnostics
        Rheumatology
        Sports Medicine
        Vascular Medicine
        Women`s Health
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
Cancer Science: #14. Does Size Matter? "Stumpy" Telomeres Allow Cancer Cells to Evade Senescence
Sara Hartley, MDLinx Oncology
  See all
Prostate cancer Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
ProCOC: the prostate cancer outcomes cohort study
BMC Urology, 07/02/08
Print     Email This Article     Save in My Library   Free Abstract
Umbehr M et al. - In a proposed study to assess how quality of life is affected depending on treatment modality as well as development of prognostic biomarkers to indicate future course of the illness, this study will provide answers to pertinent questions concerning prognosis and outcomes of men with localised prostate cancer

Methods
  • The trial will include pts with newly diagnosed localized prostate cancer independent of treatment finally chosen
  • Clinical data will be acquired including quality of life and lifestyle, prostate tissue specimen as well as further biological samples before, during and after treatment for setup of a bio-bank
  • Assessment of these data and samples in the follow up will be done during routine controls
  • Influence of treatment on morbidity and mortality, including changes in quality of life, will be identified and an evaluation of biomarkers will be performed
  • A bio-bank containing blood and urine samples will be set up providing research of various natures around prostate cancer in the future

Results
  • Study duration will be at least 10 years

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.